Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Teva Prepares To Fight Appeal After US Narcan Victory
Four Patents For Naloxone Spray Invalidated By District Court, But Appeal Looms
Jun 09 2020
•
By
David Wallace
The ruling invalidated four Narcan patents • Source: Shutterstock
More from Legal & IP
More from Generics Bulletin